238 related articles for article (PubMed ID: 36004627)
1. Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
Brusca SB; Elinoff JM; Zou Y; Jang MK; Kong H; Demirkale CY; Sun J; Seifuddin F; Pirooznia M; Valantine HA; Tanba C; Chaturvedi A; Graninger GM; Harper B; Chen LY; Cole J; Kanwar M; Benza RL; Preston IR; Agbor-Enoh S; Solomon MA
Circulation; 2022 Oct; 146(14):1033-1045. PubMed ID: 36004627
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA methylation reveals cell-specific tissue injury and correlates with disease severity and patient outcomes in COVID-19.
Li YY; Yuan MM; Li YY; Li S; Wang JD; Wang YF; Li Q; Li J; Chen RR; Peng JM; Du B
Clin Epigenetics; 2024 Mar; 16(1):37. PubMed ID: 38429730
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
4. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.
Andargie TE; Tsuji N; Seifuddin F; Jang MK; Yuen PS; Kong H; Tunc I; Singh K; Charya A; Wilkins K; Nathan S; Cox A; Pirooznia M; Star RA; Agbor-Enoh S
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33651717
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension.
Zhong L; Leng S; Alabed S; Chai P; Teo L; Ruan W; Low TT; Wild JM; Allen JC; Lim ST; Tan JL; Yip JW; Swift AJ; Kiely DG; Tan RS
JACC Cardiovasc Imaging; 2023 Aug; 16(8):1022-1034. PubMed ID: 37052561
[TBL] [Abstract][Full Text] [Related]
6. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
8. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
[TBL] [Abstract][Full Text] [Related]
10. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
Diekmann F; Chouvarine P; Sallmon H; Meyer-Kobbe L; Kieslich M; Plouffe BD; Murthy SK; Lichtinghagen R; Legchenko E; Hansmann G
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445297
[TBL] [Abstract][Full Text] [Related]
11. ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
Griffiths M; Yang J; Simpson CE; Vaidya D; Nies M; Brandal S; Damico R; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Rosenzweig EB; Hirsch R; Yung D; Nichols WC; Everett AD
Chest; 2021 Jul; 160(1):297-306. PubMed ID: 33609516
[TBL] [Abstract][Full Text] [Related]
12. Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease.
Tang P
Hellenic J Cardiol; 2020; 61(1):26-30. PubMed ID: 29890280
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S
J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078
[TBL] [Abstract][Full Text] [Related]
15. Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience.
Deshwal H; Weinstein T; Salyer R; Thompson J; Cefali F; Fenton R; Bondarsky E; Sulica R
Ther Adv Respir Dis; 2023; 17():17534666231199693. PubMed ID: 37795626
[TBL] [Abstract][Full Text] [Related]
16. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
Khirfan G; Almoushref A; Naal T; Abuhalimeh B; Dweik RA; Heresi GA; Tonelli AR
Chest; 2020 Dec; 158(6):2546-2555. PubMed ID: 32629034
[TBL] [Abstract][Full Text] [Related]
17. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
[TBL] [Abstract][Full Text] [Related]
20. Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.
Rhodes CJ; Wharton J; Boon RA; Roexe T; Tsang H; Wojciak-Stothard B; Chakrabarti A; Howard LS; Gibbs JS; Lawrie A; Condliffe R; Elliot CA; Kiely DG; Huson L; Ghofrani HA; Tiede H; Schermuly R; Zeiher AM; Dimmeler S; Wilkins MR
Am J Respir Crit Care Med; 2013 Feb; 187(3):294-302. PubMed ID: 23220912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
